布加替尼 Alunbrig (brigatinib)

[ Popularity: 168 | Date: 2022-04-18 | Return | Print ] brigatinib Alunbrig Drug name: brigatinib Alunbrig
Drug alias: brigatinib
English name: Alunbrig
Drug price: HK$ Please consult WeChat customer service
R&D company: Takeda Pharmaceutical
Indications: Anaplastic lymphoma kinase (ALK)-metastatic non-small cell lung cancer
Model specification: Tablets: 30 mg and 90 mg
Drug details:

brigatinib Alunbrig_Hong Kong Jimin Pharmaceutical

[Function and indications] On April 28, 2017, the US FDA approved it for patients with anaplastic lymphoma kinase (ALK)-metastatic non-small cell lung cancer (NSCLC) or intolerant to crizotinib

[Model and specification] Tablets: 30 mg and 90 mg

[Usage and dosage] 90 for the first 7 days mg orally once a day, if tolerated, increase to 180 mg orally once a day. Can be taken with or without food.

[Adverse Reactions] The most common adverse reactions (≥25%) are nausea, diarrhea, fatigue, cough, and headache

[Manufacturer] Takeda Pharmaceuticals